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abstract
 
ATP-sensitive potassium (K
 
ATP
 
) channels are reversibly inhibited by intracellular ATP. Agents that in-
teract with sulfhydryl moieties produce an irreversible inhibition of K
 
ATP
 
 channel activity when applied to the in-
tracellular membrane surface. ATP appears to protect against this effect, suggesting that the cysteine residue with
which thiol reagents interact may either lie within the ATP-binding site or be inaccessible when the channel is
closed. We have examined the interaction of the membrane-impermeant thiol-reactive agent 
 
p
 
-chloromercuriphenyl-
sulphonate (pCMPS) with the cloned 
 
b
 
 cell K
 
ATP
 
 channel. This channel comprises the pore-forming Kir6.2 and
regulatory SUR1 subunits. We show that the cysteine residue involved in channel inhibition by pCMPS resides on
the Kir6.2 subunit and is located at position 42, which lies within the NH
 
2 
 
terminus of the protein. Although ATP
protects against the effects of pCMPS, the ATP sensitivity of the K
 
ATP
 
 channel was unchanged by mutation of C42
to either valine (V) or alanine (A), suggesting that ATP does not interact directly with this residue. These results
are consistent with the idea that C42 is inaccessible to the intracellular solution, and thereby protected from inter-
action with pCMPS when the channel is closed by ATP. We also observed that the C42A mutation does not affect
the ability of SUR1 to endow Kir6.2 with diazoxide sensitivity, and reduces, but does not prevent, the effects of
MgADP and tolbutamide, which are mediated via SUR1. The Kir6.2-C42A (or V) mutant channel may provide a
suitable background for cysteine-scanning mutagenesis studies.
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introduction
 
ATP-sensitive K channels (K
 
ATP
 
 channels) couple elec-
trical activity to the metabolic state of the cell in a vari-
ety of tissues, including muscle, nerve, and endocrine
cells (Ashcroft and Ashcroft, 1990; Nichols and Led-
erer, 1991; Quayle et al., 1997; Trapp and Ashcroft,
1997). These channels are inhibited by ATP and acti-
vated by MgADP and it is currently thought that meta-
bolic regulation of the K
 
ATP
 
 channel is achieved through
changes in the cytosolic levels of these nucleotides.
K
 
ATP
 
 channels are also blocked by sulfonylurea drugs,
which are used to treat non–insulin-dependent diabe-
tes mellitus, and activated by a group of chemically un-
related drugs collectively known as K channel openers
(Ashcroft and Ashcroft, 1992; Edwards and Weston,
1993). Recent studies have demonstrated that the 
 
b
 
 cell
K
 
ATP
 
 channel is an octameric 4:4 complex of two struc-
turally distinct proteins: an inwardly rectifying K chan-
nel subunit, Kir6.2, and a sulfonylurea receptor, SUR1
(Inagaki et al., 1995, 1997; Sakura et al., 1995; Clement
et al., 1997; Shyng and Nichols, 1997). Both subunits
are required for functional expression. Kir6.2 acts as an
ATP-sensitive pore, while SUR1 is a regulatory subunit
that endows Kir6.2 with sensitivity to sulfonylureas,
K-channel openers, and the potentiatory effects of Mg
nucleotides such as MgADP (Nichols et al., 1996; Grib-
ble et al., 1997
 
a
 
; Shyng et al., 1997; Trapp et al., 1997;
Tucker et al., 1997). Two different sulfonylurea recep-
tor genes have been cloned, SUR1 and SUR2, that en-
code proteins with different pharmacological sensitivity
and show different tissue expression (Chutkow et al.,
1996; Inagaki et al., 1996; Isomoto et al., 1996). K
 
ATP
 
channels in pancreatic 
 
b 
 
cells comprise Kir6.2 and
SUR1 subunits, while those of cardiac muscle appear to
be composed of Kir6.2 and a splice variant of SUR2,
SUR2A (Aguilar-Bryan et al., 1998).
Agents that interact with sulfhydryl (
 
2
 
SH) moieties
produce an irreversible inhibition of both 
 
b 
 
cell and
cardiac muscle K
 
ATP
 
 channel activity when applied to
the intracellular membrane surface (Weik and Neumcke,
1989; Lee et al., 1994; Coetzee et al., 1995). Inhibition
can be reversed, however, by subsequent application of
the reducing agent dithiothreitol (DTT).
 
1
 
 These results
argue that a sulfhydryl group, and thus a cysteine resi-
due, is associated with the normal function of the K
 
ATP
 
channel. ATP appears to protect against the effects of
thiol reagents, for if ATP is applied before the sulfhy-
 
Address correspondence to Frances M. Ashcroft, University Labora-
tory of Physiology, Parks Road, Oxford OX1 3PT, UK. Fax: 44-1865-
272469; E-mail: frances.ashcroft@physiol.ox.ac.uk
 
1
 
Abbreviations used in this paper:
 
 DTT, dithiothreitol; pCMPS, 
 
p
 
-chlo-
romercuriphenylsulphonate.
  
326
 
Sulfhydryl Modification of ATP-sensitive K Channels
 
dryl-modifying agent is added, and removed after it is
washed out, the irreversible inhibition of channel activ-
ity is substantially reduced (Weik and Neumcke, 1989;
Lee et al., 1994). A similar protective effect was ob-
served with the sulfonylurea tolbutamide, which also
blocks the K
 
ATP
 
 channel (Lee et al., 1994). A possible
explanation for the ability of both ATP and tolbuta-
mide to protect against the effects of sulfhydryl agents
is that the critical cysteine is not accessible when the
channel is closed.
In the present study, we examined the interaction of the
membrane-impermeant thiol-reactive agent 
 
p
 
-chloromer-
curiphenylsulphonate (pCMPS) with the K
 
ATP
 
 channel.
We used a truncated isoform of Kir6.2 (Kir6.2
 
D
 
C26),
which expresses ATP-sensitive channel activity in the ab-
sence of a sulfonylurea receptor (Tucker et al., 1997), to
demonstrate that the cysteine residue involved in chan-
nel inhibition by pCMPS lies on Kir6.2. Using site-
directed mutagenesis, we show that this residue is lo-
cated at position 42, which lies within the intracellular
NH
 
2 
 
terminus of the protein. The ATP sensitivity of the
channel was unchanged by mutation of C42 to either
valine or alanine, suggesting that ATP does not interact
directly with this residue. It remains possible, however,
that C42 lies within the ATP-binding motif, although it
does not contribute to the affinity for ATP. Our results in-
dicate that C42 is inaccessible to the intracellular solution,
and thereby protected against inhibition by pCMPS, when
the channel is closed by ATP. They also suggest that the
inhibitory effect of pCMPS is state dependent.
 
materials and methods
 
Molecular Biology
 
Mouse Kir6.2 (Genbank D50581; Inagaki et al., 1995; Sakura et al.,
1995) and rat SUR1 (Genbank L40624; kindly provided by Dr. G.
Bell, University of Chicago, Chicago, IL; Aguilar-Bryan et al.,
1995) were used in this study. A 26 amino acid COOH-terminal
deletion of mouse Kir6.2 (Kir6.2
 
D
 
C26) was also used (Tucker et al.,
1997). Site-directed mutagenesis of Kir6.2
 
D
 
C26 was carried out
by subcloning the appropriate fragments into the pALTER vector
(Promega, Madison, WI). The mutations are indicated by the sin-
gle amino acid letter code. Synthesis of capped mRNA was car-
ried out using the mMessage mMachine large scale in vitro tran-
scription kit (Ambion Inc., Austin, TX).
 
Electrophysiology
 
Oocyte collection.
 
Female 
 
Xenopus laevis
 
 were anaesthetized with
MS222 (2 g/liter in water). One ovary was removed via a mini
laparotomy, the incision was sutured, and the animal was allowed
to recover. Once the wound had completely healed, the second
ovary was removed in a similar operation and the animal was
then killed by decapitation while under anaesthesia. Immature
stage V–VI 
 
Xenopus
 
 oocytes were incubated for 60 min with 1.0
mg/ml collagenase (type V; Sigma Chemical Co., St. Louis, MO)
and manually defolliculated. In most experiments, oocytes were
injected with 
 
z
 
2 ng of mRNA encoding Kir6.2
 
D
 
C26 (either
wild  type or mutant). For coexpression experiments, 
 
z
 
0.04 ng of
full-length Kir6.2 (wild type or mutant) was coinjected with 
 
z
 
2 ng
of SUR1 (giving a 1:50 ratio). The final injection volume was 
 
z
 
50
nl/oocyte. Control oocytes were injected with water. Isolated oo-
cytes were maintained in tissue culture and studied 1–4 d after in-
jection (Gribble et al., 1997
 
b
 
).
Macroscopic currents were recorded from giant excised inside-
out patches at a holding potential of 0 mV and at 20–24
 
8
 
C (Grib-
ble et al., 1997
 
b
 
). Currents were evoked by repetitive 3-s voltage
ramps from 
 
2
 
110 to 
 
1
 
100 mV and recorded using an EPC7
patch-clamp amplifier (List Electronik, Darmstadt, Germany).
They were filtered at 0.2 kHz, digitized at 0.5 kHz using a Digi-
data 1200 Interface and analyzed using pClamp software (Axon
Instruments, Burlingame, CA).
The pipette solution contained (mM): 140 KCl, 1.2 MgCl
 
2
 
, 2.6
CaCl
 
2
 
, 10 HEPES, pH 7.4 with KOH, and the internal (bath) solu-
tion contained (mM): 110 KCl, 2 MgCl
 
2
 
, 1 CaCl
 
2
 
, 30 KOH, 10
EGTA, 10 HEPES, pH 7.2 with KOH, and nucleotides as indi-
cated. pCMPS was dissolved directly in the solution. Tolbutamide
was made up as a 0.05 M stock solution in 0.1 M KOH and diazox-
ide as a 0.02 M stock solution in 0.1 M KOH. Solutions contain-
ing nucleotides were made up fresh each day. The pH of all solu-
tions was checked and readjusted, if required, after drug and nu-
cleotide addition. Rapid exchange of solutions was achieved by
positioning the patch in the mouth of one of a series of adjacent
inflow pipes placed in the bath.
 
Data Analysis
 
The slope conductance was measured by fitting a straight line to
the current–voltage relation between 
 
2
 
20 and 
 
2
 
100 mV. The av-
erage of five consecutive ramps was calculated in each solution.
ATP dose–response relationships were measured by alternat-
ing the control solution with a test ATP concentration. The ex-
tent of inhibition by ATP was then expressed as a fraction of the
mean of the value obtained in the control solution before and af-
ter ATP application. Dose–response curves were fitted to the Hill
equation 
 
G
 
/
 
G
 
c
 
 
 
5 
 
1/{1 
 
1 
 
([ATP]/
 
K
 
i
 
)
 
h
 
}, where [ATP] is the ATP
concentration, 
 
K
 
i 
 
is the ATP concentration at which inhibition is
half maximal, and 
 
h
 
 is the slope factor (Hill coefficient). The
time course of the block by pCMPS was fit with a monoexponen-
tial function to obtain the time constant of block.
 
results
 
Effects of pCMPS on the K
 
ATP 
 
Wild-Type Channel
 
We first investigated whether the effect of sulfhydryl-
modifying reagents on the cloned 
 
b
 
 cell K
 
ATP
 
 channel
(Kir6.2/SUR1) was the same as that reported for native
K
 
ATP
 
 channels (Weik and Neumcke, 1989; Lee et al.,
1994; Coetzee et al., 1995). Fig.1 
 
A
 
 shows that the sulf-
hydryl reagent pCMPS (50 
 
m
 
M) produced a complete
block of Kir6.2/SUR1 currents when applied to the in-
tracellular surface of an inside-out patch. Inhibition
was not reversible on removal of pCMPS, but applica-
tion of the reducing agent DTT partially restored the
current. In seven patches, 5 mM DTT restored the cur-
rent amplitude to 31 
 
6
 
 4% of its control value. This
supports the idea that the inhibitory effect of pCMPS is
mediated by sulfhydryl modification of the channel.
The fact that the current amplitude did not recover to
its original value may be due to an incomplete action of
DTT, which acts only slowly at physiological pH. Alter- 
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natively, it may reflect the presence of rundown, a time-
dependent decline in channel activity that is observed
for both native and cloned K
 
ATP
 
 channels in excised
patches.
ATP has been shown to protect against the effects of
thiol reagents on native K
 
ATP
 
 channels (Weik and
Neumcke, 1989; Lee et al., 1994). This was also the case
for Kir6.2/SUR1 currents (Fig. 1 
 
B
 
). Provided that the
patch was exposed to pCMPS in the continuous pres-
ence of ATP, the sulfhydryl reagent did not induce an
irreversible block and the currents recovered on re-
moval of ATP (to 40 
 
6
 
 13% of the control value, 
 
n
 
 5
 
5). This suggests that the cysteine residue with which
the thiol reagent interacts is not accessible from the in-
tracellular solution when the channel is inhibited by
ATP, either because it is not exposed when the channel
is closed by ATP, or because access to the cysteine resi-
due is occluded by the presence of ATP in its binding
site.
 
Effects of pCMPS on Kir6.2
 
D
 
C26 Currents
 
We next explored whether the site at which thiol re-
agents interact with the K
 
ATP
 
 channel lies on the pore-
forming Kir6.2 subunit, or on SUR1, by examining the
effect of pCMPS on a truncated isoform of Kir6.2
(Kir6.2
 
D
 
C26) that is able to form functional channels in-
dependently of SUR1. Fig. 2 shows that 50 
 
m
 
M pCMPS
completely inhibited Kir6.2
 
D
 
C26 currents and that
DTT was able to partially reverse this inhibition. This
result indicates that pCMPS block is not mediated by
SUR1, and further suggests that the thiol reagent inter-
acts either directly with Kir6.2
 
D
 
C26 or (possibly) with a
third protein, endogenously expressed in 
 
Xenopus
 
oocytes, that modulates the activity of Kir6.2
 
D
 
C26.
 
Cysteine Mutations Identify the Residue Involved in 
pCMPS Block
 
To determine whether pCMPS interacts directly with
Kir6.2, and to identify the cysteine residue involved, we
carried out site-directed mutagenesis of Kir6.2
 
D
 
C26.
The critical cysteine is accessible to the intracellular so-
lution and must therefore lie either on the NH
 
2
 
 or
COOH terminus of Kir6.2
 
D
 
C26, or within the inner
mouth of the channel pore itself. There are five cys-
teines within these regions of Kir6.2
 
D
 
C26, at positions
42, 81, 166, 197, and 344 (Fig. 3 
 
A
 
). We therefore
tested the effects of mutating each of these, in turn, to
serine.
Currents expressed by Kir6.2
 
D
 
C26 containing either
the C81S or C344S mutations were of similar amplitude
to wtKir6.2
 
D
 
C26, while those containing the C166S mu-
tation were approximately sevenfold larger (see accom-
panying paper, Trapp et al., 1998). For all three mutant
channels, 50 
 
m
 
M pCMPS caused a complete block of
the current. Functional expression of Kir6.2
 
D
 
C26-C42S
and Kir6.2
 
D
 
C26-C197S channels was too low to be able
to study: only rare single-channel openings were ob-
served in excised patches containing Kir6.2
 
D
 
C26-C42S,
and none were detected in patches excised from oo-
cytes injected with Kir6.2
 
D
 
C26-C197S mRNA. We there-
fore tested the effect of both alanine and valine substi-
tutions at positions 42 and 197. When expressed alone,
Figure 1. Effects of pCMPS on wild-type K-ATP currents. Macro-
scopic currents recorded from oocytes coinjected with mRNAs en-
coding Kir6.2 and SUR1 in response to a series of voltage ramps
from 2110 to 1100 mV. pCMPS, DTT, or ATP were added to the
internal solution as indicated by the bars. The dashed line indi-
cates the zero current level.
Figure 2. Effects of pCMPS on Kir6.2DC26 currents. Macro-
scopic currents recorded from an inside-out patch excised from an
oocyte injected with Kir6.2DC26 mRNA in response to voltage
ramps from 2110 to 1100 mV. pCMPS and DTT were added to
the internal solution as indicated by the bars. 
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these mutants only produced very small currents but,
when coexpressed with SUR1, significant functional ex-
pression was observed for Kir6.2
 
D
 
C26 containing the
C197A, C197V, C42A, or C42V mutations. This suggests
that C42 and C197 may be needed for correct targeting
of the truncated Kir6.2 isoform to the surface mem-
brane, or for its functional activity.
Mutation of C197 did not prevent inhibition by
pCMPS. By contrast, pCMPS was without effect on
Kir6.2
 
D
 
C26-C42V/SUR1 currents (Fig. 3 
 
B
 
), nor did it af-
fect the K
 
ATP
 
 currents observed when the full length form
of Kir6.2 containing the C42A mutation was coexpressed
with SUR1 (Fig. 3 
 
C
 
). These results confirm that pCMPS
inhibits the K
 
ATP 
 
channel by interaction with Kir6.2,
rather than with an endogenous oocyte protein. A single
cysteine residue in Kir6.2, at position 42, which lies in the
cytosolic NH
 
2
 
-terminal part of the protein, appears to be
the target for the inhibitory action of pCMPS. Since
SUR1 was present in these experiments, they also indi-
cate that pCMPS does not interact with additional sites
on SUR1 to inhibit channel activity: in wild-type chan-
nels, the presence of such sites would be masked by the
inhibitory effect of the thiol agent on Kir6.2.
We next examined the rate of pCMPS block of the
mutant channels (with the exception of C42A and
Figure 3. Mutation of C42 abolishes pCMPS but not ATP block of
KATP currents. (A) Putative membrane topology of Kir6.2 with the
location of intracellular cysteine residues marked. (B and C) Macro-
scopic currents recorded from inside-out patches excised from
oocytes coinjected with either Kir6.2DC26-C42V and SUR1 mRNAs
(B) or Kir6.2-C42A and SUR1 mRNAs (C). Currents were recorded
in response to voltage ramps from 2110 to 1100 mV. pCMPS and
ATP were added to the internal solution as indicated by the bars.
Figure 4. Effect of cysteine mutations on the rate of pCMPS
block. (A and B) Macroscopic currents recorded at 2100 mV from
inside-out patches excised from oocytes injected with Kir6.2DC26
or Kir6.2DC26-C166S mRNA. pCMPS was added to the internal so-
lution as indicated by the bars. The dotted line indicates the zero
current level and the dashed line is an extrapolated linear fit to the
slope of the rundown in control solution and extrapolated. (C)
Mean time constant for pCMPS block of wild-type and mutant
Kir6.2DC26 channels (open bars), and for Kir6.2 or Kir6.2DC26-
C197V coexpressed with SUR1 (solid bars). The number of oocytes
is given above the bars. *P 5 0.0005 against wild-type Kir6.2DC26
currents (wt). 1P , 0.005 against wild-type (Kir6.2/SUR1) cur-
rents.329 Trapp et al.
C42V, which are not blocked). The rate of block at
2100 mV was quantified by fitting a single exponential
to the decay of the current after pCMPS application,
and the mean time constants for the different cysteine
mutations are plotted in Fig. 4 C. The mutant channels
were fully blocked by pCMPS and, with two exceptions,
the kinetics of the block were similar to those observed
for both Kir6.2DC26 and Kir6.2/SUR1 currents. The
rate of block of Kir6.2DC26-C197V currents was slightly
increased, while that of Kir6.2DC26-C166S was mark-
edly slowed. However, mutation of C166 to valine did
not alter the kinetics of inhibition by pCMPS: this may
reflect the fact that the C166V mutation, unlike C166S,
did not alter the single-channel kinetics (see Trapp et
al., 1998). The rate of block of wild-type Kir6.2/SUR1
channels by pCMPS (100 mM) was unaffected by mem-
brane potential, being 1.36 6 0.32 s (n 5 7) at 2100
mV and 1.76 6 0.20 s (n 5 7) at 1100 mV.
One possible explanation for the ability of ATP to pro-
tect against the effects of pCMPS is that the critical cys-
teine lies within, or close to, the ATP-binding site and is
thus inaccessible when ATP is bound. We therefore com-
pared the ATP sensitivity of Kir6.2DC26-C42V/SUR1
currents with that of Kir6.2DC26/SUR1 currents (Fig. 5,
A and B). Application of 1 mM ATP to the inner mem-
brane surface markedly inhibited both currents. There
was no significant difference in the ATP sensitivity of the
channels, half-maximal inhibition being produced by
13 6 1 mM ATP (n 5 4) for Kir6.2DC26-C42V/SUR1
and by 18 6 3 mM ATP (n 5 5) for Kir6.2DC26/SUR1
currents. In both cases, the Hill coefficient was close to
unity: 0.91 6 0.07 for Kir6.2DC26-C42V/SUR1 and
0.92 6 0.14 for Kir6.2DC26/SUR1 currents. Thus, the
C42V mutation does not influence the block by ATP.
No change in ATP sensitivity was observed for the
Kir6.2DC26 isoform containing either the C81S or
C344S mutation, nor for Kir6.2DC26-C197V/SUR1 cur-
rents or Kir6.2-C42A/SUR1 currents (Fig. 5). When
C166 was replaced by serine, however, the ATP sensitiv-
ity of the channel was markedly reduced (Fig. 5; see
Trapp et al., 1998). It is worth noting that in addition
to removing the pCMPS sensitivity, the C42V mutation
also induces an increased rate of rundown of the cur-
rent, and an accompanying increase in the refreshment
of the current after MgATP application (Fig. 5 A).
Figure 5.  (A) Macroscopic currents recorded from inside-out
patches in response to a series of voltage ramps from 2110 to
1100 mV from oocytes injected with mRNAs encoding SUR1 and
either Kir6.2DC26 or Kir6.2DC26-C42V. ATP was added to the in-
ternal solution as indicated by the bar. (B) Mean ATP dose–
response relationships for Kir6.2DC26/SUR1 currents (s, n 5 5)
and Kir6.2DC26-C42V/SUR1 currents (d, n 5 4). Test solutions
were alternated with control solutions and the slope conductance
(G) is expressed as a percentage of the mean (Gc) of that obtained
in control solution before and after exposure to ATP. Conduc-
tance was measured between 220 and 2100 mV and is the mean
of five voltage ramps. The lines are the best fit of the data to the
Hill equation using the mean values for Ki and h given in the text.
(C) Mean current amplitude recorded during exposure to ATP,
expressed as a fraction of the mean current amplitude before and
after exposure to ATP for patches excised from oocytes injected
with wild-type or mutant Kir6.2DC26 mRNAs (top), or wild-type or
mutant Kir6.2 together with SUR1 (bottom). The dashed line indi-
cates the control current level (in the absence of ATP). The num-
ber of oocytes is given above the bars.330 Sulfhydryl Modification of ATP-sensitive K Channels
Coupling to SUR1
We next examined the effect of mutating C42 on the
ability of SUR1 to couple to Kir6.2, by coexpressing the
full length version of Kir6.2 containing the C42A muta-
tion (Kir6.2-C42A) with SUR1. Since Kir6.2 does not ex-
press functional channels independently of SUR, this
procedure ensures that the KATP current we record only
reflects current flow through octameric channels com-
prising both Kir6.2-C42A and SUR1 subunits. We com-
pared the ability of MgADP, diazoxide, and tolbutamide,
all of which interact with SUR1, to influence the activity
of wild-type and mutant KATP channels. The stimulatory
effect of diazoxide requires the presence of hydrolyzable
nucleotides at the inner face of the membrane (Dunne,
1989; Kozlowski et al., 1989) and we therefore tested the
ability of this drug to activate channels partially blocked
by 100 mM ATP. Fig. 6 shows that the stimulatory effect
of diazoxide was not significantly different for Kir6.2-
C42A/SUR1 and wild-type KATP currents (unpaired t
test). By contrast, both MgADP and tolbutamide were
less effective when C42 was mutated. Thus, 100 mM
MgADP was without significant effect on Kir6.2-C42A/
SUR1 currents, in contrast to the potentiatory effect of
the nucleotide on Kir6.2/SUR1 currents (P 5 0.007). In
addition to the potentiatory effect of MgADP mediated
by the nucleotide-binding domains of SUR1, ADP inhib-
its the KATP channel by interaction with Kir6.2 (Gribble
et al., 1997a). Complete abolition of the stimulatory
effects of MgADP unmasks the inhibitory effect of ADP,
reducing the current to z50% of its control value
(Gribble et al., 1997a). Since inhibition of Kir6.2-C42A/
SUR1 currents by MgADP was not observed, the stimula-
tory effect of MgADP must be impaired but not abol-
ished by the mutation. Tolbutamide was also less effec-
tive when C42 was mutated (P 5 0.017; Fig. 6). Thus,
mutation of C42 to alanine reduces, but does not pre-
vent, the ability of SUR1 to transduce binding of MgADP
and tolbutamide into changes in Kir6.2 gating.
discussion
Both native KATP channels and the cloned wild-type b
cell KATP channel (Kir6.2/SUR1) are blocked by the
sulfhydryl reagent pCMPS with a time constant of z3 s.
Our results argue that this effect involves interaction of
the sulfhydryl reagent with the cysteine residue at posi-
tion 42 of Kir6.2. Mutation of C42 to either alanine or
Figure 6. Coupling to SUR1 is reduced when C42 in Kir6.2 is mutated to alanine or valine. (A and B) Macroscopic currents recorded from
inside-out patches in response to a series of voltage ramps from 2110 to 1100 mV from oocytes injected with mRNAs encoding SUR1 and
either wtKir6.2 or Kir6.2-C42A. MgADP, ATP, diazoxide (DZ), or tolbutamide (TB) were added to the internal solution as indicated by the
bars. (C) Mean macroscopic slope conductance recorded in the presence of MgADP, diazoxide, or tolbutamide, expressed as a percentage
of the slope conductance in control solution (no additions), for the indicated channels. Diazoxide was added in the presence of MgATP.
The dashed line indicates the current level in control solution. The number of oocytes is given above the bars. *P , 0.01; 1P , 0.05.331 Trapp et al.
valine abolished the inhibitory effect of pCMPS, while
mutation of the cysteine residues at positions 81, 166,
197, and 344 had no effect on the magnitude of pCMPS
block. The ability of these mutant channels to express
functional currents suggests that none of the mutated
cysteines participate in disulfide bonds that are critical
for channel formation. Although the kinetics of pCMPS
block were altered when C166 was mutated to serine,
this was not observed for the C166V mutation, indicat-
ing that this cysteine is also not involved in inhibition
by thiol reagents. The ability of intracellular pCMPS to
interact with C42 also implies that the NH2 terminus of
Kir6.2 is intracellular, as suggested by hydropathy anal-
ysis and by analogy with other Kir channels. The block
by pCMPS is not obviously voltage dependent, which
implies that C42 lies outside the membrane voltage
field and is again consistent with an intracellular loca-
tion for the NH2 terminus. It is noteworthy that one or
more cysteine residues in the NH2 terminus of the volt-
age-gated K1 channel Kv2.1 must also be targeted by
sulfhydryl reagents, since deletion of the NH2 terminus
(which contains six cysteines) largely abolishes the ef-
fect of these reagents (Pascaul et al., 1997).
Effects of C166 Mutation
Mutation of C166S markedly enhanced the level of cur-
rent expression. This effect can be entirely explained
by the fact that the mutation alters the single-channel
kinetics and enhances the channel open probability,
rather than affecting the single-channel conductance
or channel density (Trapp et al., 1998).
The simplest kinetic model of the KATP channel as-
sumes the presence of a single open state and two
closed states, one short and one long (Trapp et al.,
1998). The slower time course of pCMPS block of
Kir6.2DC26-166S currents argues that the thiol reagent
may not block the open state of the channel, which is
markedly increased in frequency by the C166S muta-
tion (Trapp et al., 1998). Consistent with this idea, the
rate of pCMPS block was unaffected in Kir6.2DC26-
C166V channels, which had single-channel kinetics
similar to those of wild-type channels. One possibility,
therefore, is that pCMPS reduces the probability of
channel reopening from the long closed state. Alterna-
tively, the C166S mutation may independently affect
channel gating and slow access to the pCMPS binding
site.
Effects of C42 Mutation
Mutation of C42 to either valine or alanine did not al-
ter the ATP sensitivity of Kir6.2DC26, indicating that a
cysteine at this site is not essential for ATP inhibition.
We cannot exclude the possibility, however, that C42 is
located close to the ATP-binding site. If access of pCMPS
to this residue in wild-type channels is physically pre-
vented by the presence of ATP in its binding site, this
would account for the ability of ATP to protect against
irreversible pCMPS inhibition. The fact that tolbuta-
mide, which primarily interacts with the SUR rather
than the Kir6.2 subunit, also protects against thiol re-
agent block of native KATP channels (Lee et al., 1994) is
less easily explained by this hypothesis. However, we
were unable to demonstrate protection against pCMPS
block of Kir6.2/SUR1 currents by tolbutamide under
our experimental conditions (not shown). Although
previous studies have implicated residues in the COOH
terminus in ATP inhibition of Kir6.2DC26 (Tucker et
al., 1997), there is also evidence that residues in the
NH2 terminus may be involved: mutation of R50, for
example, may also markedly alter the ATP sensitivity
(Tucker et al., 1998). It remains unclear, however,
whether the ATP-binding site involves residues in both
the NH2 and COOH terminus, whether mutations in
the NH2 terminus allosterically influence an ATP-bind-
ing site in the COOH-terminal part of the molecule or if
the NH2 and COOH termini cooperate in channel clo-
sure by ATP. A precedent for the latter possibility is
provided by the cyclic nucleotide-activated channels,
where the cyclic nucleotide binding site is located in
the COOH terminus, but channel activation is modi-
fied by physical interaction between the NH2 and
COOH termini (Gordon and Zagotta, 1995; Varnum
and Zagotta, 1997).
The mechanism by which SUR1 enables functional
expression of full-length Kir6.2 was unaffected by the
C42A mutation. Likewise, the ability of SUR1 to confer
diazoxide sensitivity on Kir6.2 was unchanged. By con-
trast, both MgADP and tolbutamide were significantly
less effective than this mutant. This suggests that C42
may be required for full functional coupling of SUR1
to Kir6.2: our data, however, do not allow us to say
whether the cysteine residue physically interacts with
SUR1, or whether the effect of its mutation on Kir6.2-
SUR1 coupling is mediated indirectly.
Conclusion
Cysteine scanning mutagenesis is a well established
method for identifying key residues involved in form-
ing the channel pore, in which individual residues are
mutated to cysteine and the ability of thiol reagents to
block the permeation pathway are investigated. Such
studies can only be carried out on a channel that has no
intrinsic sensitivity to thiol reagents. This is not the case
for either the wild-type KATP channel or the Kir6.2DC26
channel. Our results demonstrate that the inhibitory ef-
fect of sulfhydryl reagents is mediated by interaction
with C42 of Kir6.2, and thus that cysteine scanning mu-
tagenesis could be performed using a Kir6.2 subunit in
which C42 has been changed.332 Sulfhydryl Modification of ATP-sensitive K Channels
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